| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |